BDMD
Baird Medical Investment Holdings Limited
There isn't enough reported data to score BDMD yet.
BDMD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BDMD's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
BDMD PE Valuation
BDMD has no meaningful PE right now: it lost money over the past year.
BDMD Forward outlook
There aren't enough analyst estimates for BDMD to show an outlook.
BDMD Earnings Per Share
BDMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $9.9M | +25% |
| Q4 2025 | $14.6M | -39% |
| Q2 2025 | $8M | -39% |
| Q4 2024 | $23.9M | +20% |
| Q2 2024 | $13.1M | +14% |
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 8.5% | -30 points |
| Q4 2025 | -104% | -149 points |
| Q2 2025 | -131% | -157 points |
| Q4 2024 | 43% | N/A |
| Q2 2024 | 39% | N/A |
| Q4 2023 | 45% | N/A |
| Q2 2023 | 26% | N/A |
BDMD's operating margin was 8.5% last quarter, down 30 points from the same quarter a year ago.
BDMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.5M | +$5.7M |
| Q4 2025 | $1.9M | +$6.6M |
| Q2 2025 | -$3.2M | +$1.2M |
| Q4 2024 | -$4.7M | -$1.7M |
| Q2 2024 | -$4.4M | -$3.8M |
BDMD Net Leverage
BDMD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BDMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.0 | Oversold |
| Stochastic | 2.1 | Oversold |
BDMD's weekly RSI is 22 (oversold) and its Stochastic is 2 (oversold).
BDMD PE vs Healthcare Sector
| Metric | BDMD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BDMD has no meaningful PE right now: it lost money over the past year.
BDMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.46 | 76% below |
| 20 week MA | $0.85 | 87% below |
| 50 week MA | $1.29 | 91% below |
| 100 week MA | $2.63 | 96% below |
BDMD is in a downtrend: it's below all four of its weekly moving averages, and 96% below its 100-week average.
BDMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $11.0 | $1.72 | -84% |
| 2025 | $1.72 | $1.40 | -19% |
| 2026 YTD | $1.40 | $0.11 | -92% |
BDMD has finished every year since 2024 lower, and it's down 92% so far in 2026.